XML 54 R44.htm IDEA: XBRL DOCUMENT v2.4.1.9
SEGMENT INFORMATION (Tables)
12 Months Ended
Dec. 31, 2014
SEGMENT INFORMATION  
Financial information regarding the Company's reportable segments

                                                                                                                                                                                    

 

 

 

 

    

 

 

 

 

 

Years Ended December 31,

 

2014

 

2013

 

2012

 

Total Sales:

 

 

 

 

 

 

 

 

 

 

Beauty + Home

 

$

1,522,444

 

$

1,501,611

 

$

1,468,599

 

Pharma

 

 

751,226

 

 

709,058

 

 

588,853

 

Food + Beverage

 

 

349,297

 

 

323,469

 

 

288,995

 

​  

​  

​  

​  

​  

​  

​  

​  

Total Sales

 

$

2,622,967

 

$

2,534,138

 

$

2,346,447

 

Less: Intersegment Sales:

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

24,147

 

$

13,466

 

$

14,659

 

Pharma

 

 

 

 

284

 

 

160

 

Food + Beverage

 

 

1,011

 

 

375

 

 

592

 

​  

​  

​  

​  

​  

​  

​  

​  

Total Intersegment Sales

 

$

25,158

 

$

14,125

 

$

15,411

 

Net Sales:

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

1,498,297

 

$

1,488,145

 

$

1,453,940

 

Pharma

 

 

751,226

 

 

708,774

 

 

588,693

 

Food + Beverage

 

 

348,286

 

 

323,094

 

 

288,403

 

​  

​  

​  

​  

​  

​  

​  

​  

Net Sales

 

$

2,597,809

 

$

2,520,013

 

$

2,331,036

 

Segment Income (1):

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

98,368

 

$

109,272

 

$

123,527

 

Pharma

 

 

204,698

 

 

189,689

 

 

141,912

 

Food + Beverage

 

 

37,728

 

 

35,186

 

 

30,415

 

Restructuring Initiatives and Related Depreciation

 

 

 

 

(14,525

)

 

(4,678

)

Corporate & Other

 

 

(38,261

)

 

(37,958

)

 

(33,849

)

​  

​  

​  

​  

​  

​  

​  

​  

Income before interest and taxes

 

$

302,533

 

$

281,664

 

$

257,327

 

Interest expense, net

 

 

(16,232

)

 

(17,281

)

 

(15,954

)

​  

​  

​  

​  

​  

​  

​  

​  

Income before income taxes

 

$

286,301

 

$

264,383

 

$

241,373

 

​  

​  

​  

​  

​  

​  

Depreciation and Amortization (1):

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

85,469

 

$

83,328

 

$

82,828

 

Pharma

 

 

41,690

 

 

39,812

 

 

33,122

 

Food + Beverage

 

 

20,179

 

 

18,871

 

 

15,605

 

Restructuring Initiatives

 

 

 

 

2,725

 

 

1,576

 

Corporate & Other

 

 

4,880

 

 

5,220

 

 

3,891

 

​  

​  

​  

​  

​  

​  

​  

​  

Depreciation and Amortization

 

$

152,218

 

$

149,956

 

$

137,022

 

Capital Expenditures:

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

76,544

 

$

81,247

 

$

97,010

 

Pharma

 

 

37,455

 

 

32,643

 

 

24,953

 

Food + Beverage

 

 

32,148

 

 

19,339

 

 

32,282

 

Corporate & Other

 

 

15,793

 

 

18,281

 

 

19,808

 

​  

​  

​  

​  

​  

​  

​  

​  

Capital Expenditures

 

$

161,940

 

$

151,510

 

$

174,053

 

Total Assets:

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

1,193,370

 

$

1,318,933

 

$

1,240,101

 

Pharma

 

 

619,304

 

 

676,420

 

 

659,132

 

Food + Beverage

 

 

263,742

 

 

253,774

 

 

233,553

 

Corporate & Other

 

 

360,774

 

 

248,635

 

 

191,626

 

​  

​  

​  

​  

​  

​  

​  

​  

Total Assets

 

$

2,437,190

 

$

2,497,762

 

$

2,324,412

 

 

(1)

The Company evaluates performance of its business units and allocates resources based upon segment income. Segment income is defined as earnings before net interest expense, certain corporate expenses, restructuring initiatives and income taxes. Restructuring Initiatives and related Depreciation includes the following income/(expense) items for the twelve months ended December 31, 2014, 2013 and 2012 as follows:

                                                                                                                                                                                    

 

 

 

 

 

 

 

 

Years Ended December 31,

 

2014

 

2013

 

2012

 

European Restructuring Plan

 

 

 

 

 

 

 

 

 

 

Depreciation

 

$

 

$

2,725

 

$

1,576

 

Employee Severance and Other Costs

 

 

 

 

11,844

 

 

3,314

 

Prior Year Initiatives

 

 

 

 

(44

)

 

(212

)

​  

​  

​  

​  

​  

​  

Total Restructuring Initiatives and Related Depreciation Expense

 

$

 

$

14,525

 

$

4,678

 

​  

​  

​  

​  

​  

​  

Restructuring Initiatives and Related Depreciation Expense by Segment

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

 

$

14,548

 

$

4,787

 

Pharma

 

 

 

 

 

 

 

Food + Beverage

 

 

 

 

(23

)

 

(109

)

​  

​  

​  

​  

​  

​  

Total Restructuring Initiatives and Related Depreciation Expense

 

$

 

$

14,525

 

$

4,678

 

​  

​  

​  

​  

​  

​  

 

Restructuring Initiatives and Related Depreciation

 

 

 

 

 

 

 

 

Years Ended December 31,

 

2014

 

2013

 

2012

 

European Restructuring Plan

 

 

 

 

 

 

 

 

 

 

Depreciation

 

$

 

$

2,725

 

$

1,576

 

Employee Severance and Other Costs

 

 

 

 

11,844

 

 

3,314

 

Prior Year Initiatives

 

 

 

 

(44

)

 

(212

)

​  

​  

​  

​  

​  

​  

Total Restructuring Initiatives and Related Depreciation Expense

 

$

 

$

14,525

 

$

4,678

 

​  

​  

​  

​  

​  

​  

Restructuring Initiatives and Related Depreciation Expense by Segment

 

 


 

 

 


 

 

 


 

 

Beauty + Home

 

$

 

$

14,548

 

$

4,787

 

Pharma

 

 

 

 

 

 

 

Food + Beverage

 

 

 

 

(23

)

 

(109

)

​  

​  

​  

​  

​  

​  

Total Restructuring Initiatives and Related Depreciation Expense

 

$

 

$

14,525

 

$

4,678

 

​  

​  

​  

​  

​  

​  

 

Schedule of net sales and long-lived asset information by geographic area and product information

                                                                                                                                                                                    

 

 

 

 

    

 

 

 

 

 

 

 

2014 

 

2013 

 

2012 

 

Net Sales to Unaffiliated Customers (1):

 

 

 

 

 

 

 

 

 

 

United States

 

$

642,060 

 

$

634,418 

 

$

650,637 

 

Europe:

 

 

 

 

 

 

 

 

 

 

France

 

 

850,817 

 

 

810,528 

 

 

650,226 

 

Germany

 

 

363,898 

 

 

339,858 

 

 

311,205 

 

Italy

 

 

141,808 

 

 

136,617 

 

 

144,163 

 

Other Europe

 

 

150,469 

 

 

165,038 

 

 

163,695 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total Europe

 

 

1,506,992 

 

 

1,452,041 

 

 

1,269,289 

 

Other Foreign Countries

 

 

448,757 

 

 

433,554 

 

 

411,110 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total

 

$

2,597,809 

 

$

2,520,013 

 

$

2,331,036 

 

​  

​  

​  

​  

​  

​  

Plant, Property & Equipment:

 

 


 

 

 


 

 

 


 

 

United States

 

$

192,265 

 

$

226,917 

 

$

191,697 

 

Europe:

 

 

 

 

 

 

 

 

 

 

France

 

 

228,049 

 

 

263,913 

 

 

251,015 

 

Germany

 

 

136,491 

 

 

156,970 

 

 

137,203 

 

Italy

 

 

48,940 

 

 

57,729 

 

 

65,743 

 

Other Europe

 

 

57,946 

 

 

72,297 

 

 

72,404 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total Europe

 

 

471,426 

 

 

550,909 

 

 

526,365 

 

Other Foreign Countries

 

 

147,964 

 

 

86,836 

 

 

130,171 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total

 

$

811,655 

 

$

864,662 

 

$

848,233 

 

​  

​  

​  

​  

​  

​  

Product Net Sales Information:

 

 


 

 

 


 

 

 


 

 

Pumps

 

$

1,111,536 

 

$

1,093,514 

 

$

1,044,226 

 

Closures

 

 

611,144 

 

 

594,135 

 

 

605,493 

 

Valves

 

 

350,106 

 

 

327,635 

 

 

327,251 

 

Injectables (2)

 

 

143,631 

 

 

142,116 

 

 

56,465 

 

Other

 

 

381,392 

 

 

362,613 

 

 

297,601 

 

​  

​  

​  

​  

​  

​  

​  

​  

Total

 

$

2,597,809 

 

$

2,520,013 

 

$

2,331,036 

 

​  

​  

​  

​  

​  

​  

 

 

(1)

Sales are attributed to countries based upon where the sales invoice to unaffiliated customers is generated.

(2)

Injectables represent six month sales in 2012 from the date of acquisition.